We previously reported the production of anti-IRS-l monoclonal antibod
ies against human IRS-1 C-terminal portion, One of anti IRS-1 monoclon
al antibodies, 6G5, was found to immunologically cross-react with IRS-
2, which has been reported recently. The data presented here provide i
nformation arising from the use of the anti-IRS-1 MAb, 6G5; this MAb w
as found to be a useful reagent in studying the functional role of IRS
s in the insulin-signaling system.